End-of-day quote
Other stock markets
|
||
- USD | - |
2023 | Avivagen Inc. Announces New 500 Kg Order for OxC-beta | CI |
2023 | Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 | CI |
Sales 2021 | 1.3M 952K 74.98M | Sales 2022 | 939K 690K 54.33M | Capitalization | 10.42M 7.65M 603M |
---|---|---|---|---|---|
Net income 2021 | -6M -4.41M -347M | Net income 2022 | -6M -4.41M -347M | EV / Sales 2021 | 21.5 x |
Net Debt 2021 | 5.4M 3.96M 312M | Net Debt 2022 | 5.8M 4.25M 335M | EV / Sales 2022 | 17.3 x |
P/E ratio 2021 |
-3.24
x | P/E ratio 2022 |
-1.47
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.89% |
Managers | Title | Age | Since |
---|---|---|---|
Graham W. Burton
FOU | Founder | - | 03/08/05 |
G. Anthony
CEO | Chief Executive Officer | 68 | 03/04/14 |
Ira Levy
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Kraws
CHM | Chairman | 59 | 30/11/13 |
Aubrey Dan
BRD | Director/Board Member | - | 21/11/17 |
G. Anthony
CEO | Chief Executive Officer | 68 | 03/04/14 |
1st Jan change | Capi. | |
---|---|---|
+16.63% | 12.02B | |
+6.55% | 6.21B | |
+4.98% | 5.42B | |
+14.80% | 5.13B | |
-19.13% | 2.74B | |
+3.80% | 1.95B | |
-12.27% | 1.29B | |
-10.05% | 958M | |
-18.43% | 946M |